|
|
Faculty
|
Brian J. Druker, MD - Director, Leukemia Center at Oregon Health Sciences University
Dr. Brian J. Druker is the Director of the Leukemia Center at Oregon Health Sciences University (OHSU). As a Professor of Medicine, he has joint appointments in the Department of Cell and Developmental Biology and the Department of Biochemistry and Molecular Biology.
Upon graduating from UC San Diego Medical School in 1981, Dr. Druker completed his internship and residency in internal medicine at Barnes Hospital: Washington School of Medicine in St. Louis, Missouri. He then trained in Oncology at Harvard's Dana-Farber Cancer Institute.
After he finished his clinical training, Dr. Druker returned to the lab to begin a research career. He studied the regulation of the growth of cancer cells and began to apply this knowledge to cancer therapies. His work has been instrumental in the development of a drug that has shown remarkable success in the treatment of patients with chronic myeloid leukemia. The clinical trials with STI571, commonly known as Gleevec, have been heralded as a new paradigm in cancer therapy. His role in the development of STI571 and application in the clinic have resulted in numerous awards for Dr. Druker, including the AACR Richard and Hinda Rosenthal Award, the John J. Kenney Award from the Leukemia and Lymphoma Society and the Warren Alpert Prize from Harvard Medical School.
Joseph M. Connors, MD, FRCPC - British Columbia Cancer Agency
Dr. Joseph M. Connors is a clinical professor at the University of British Columbia in Vancouver and Head of the Lymphoma Tumor Group for the British Columbia Cancer Agency. Before moving to Canada in 1981, Dr. Connors taught at the University of Washington School of Medicine, at Alaska Native Medical Center in Anchorage, and North Carolina Memorial Hospital. A graduate of Yale Medical School, he trained with Dr. Saul Rosenberg at Stanford University and decided to focus his research efforts in understanding lymphoproliferative diseases. Dr. Connors has received grant funding for numerous clinical trials and has published over 100 peer- reviewed scientific articles. He currently serves on LRFA's Honorary Medical Board and is a founding member of Lymphoma Research Foundation Canada. Despite his busy schedule, he sets aside a week every year to teach a high school class on cancer and medicine.
|
|
|
